Vanda Pharmaceuticals Inc.
VNDA
$4.29
-$0.04-0.92%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
4/19/2025
-
MarketBeat
4/18/2025
-
Tickeron - Stocks
4/16/2025
-
MarketBeat
4/15/2025
-
Tickeron - Technical Analysis
4/15/2025
-
MarketBeat
4/14/2025
-
MarketBeat
4/11/2025
-
FiercePharma
4/10/2025
-
ETF Channel
4/7/2025
-
SeekingAlpha
4/7/2025
-
GuruFocus
4/7/2025
-
PR Newswire
4/4/2025
-
Tickeron - Stocks
4/3/2025
-
MarketBeat
4/2/2025
-
MarketBeat
3/31/2025
-
The Fly
3/31/2025
-
PR Newswire
3/29/2025
-
Tickeron - Stocks
3/28/2025
-
Tickeron - Technical Analysis
3/24/2025
-
BizJournals.com - Nat'l Business News
3/22/2025
-
Tickeron - Stocks
3/13/2025
-
MarketBeat
3/10/2025
-
ETF Channel
3/7/2025
-
Tickeron - Technical Analysis
3/7/2025
-
Tickeron - Stocks
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, February 14, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
202 734 3400
Address
2200 Pennsylvania Avenue NW
Washington, DC 20037
Washington, DC 20037
Country
Year Founded
Business Description
Sector
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company’s marketed...
more